SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): January 8, 2004
Unigene Laboratories, Inc.
(Exact name of Registrant as specified in its charter)
| Delaware | 0-16005 | 22-2328609 | ||
(State or Other Jurisdiction of Incorporation or Organization) | (Commission File Number) ) | (I.R.S. Employer Identification No.) |
110 Little Falls Road
Fairfield, New Jersey 07004
(973) 882-0860
(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)
Not applicable
(Former name or former address, if changed since last report)
ITEM 5. OTHER EVENTS AND REQUIRED FD DISCLOSURE.
On January 8, 2004, the Registrant issued a press release that is attached hereto as exhibit 99.1 and incorporated by reference.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
| (c) | Exhibits. |
| 99.1 | The Registrant’s Press Release dated January 8, 2004. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
UNIGENE LABORATORIES, INC. | ||||
/s/ Warren P. Levy | ||||
Date: January 8, 2004 | By: | Warren P. Levy | ||
Title: | President | |||
